Hints and tips:
...It was under his successor, Sir Richard Sykes, that Glaxo undertook two major transactions — acquiring Wellcome in 1995 and merging with SmithKline Beecham in 2000 — which radically altered the portfolio...
...Glaxo first bought Wellcome in 1995 and then SmithKline Beecham in 2000, becoming GSK. Glencore acquired Xstrata in 2013....
...SmithKline Beecham (now part of GSK) pulled its successful Lyme disease vaccine in the early 2000s amid rising anti-vaccine sentiment....
...He pointed to the merger, almost 20 years ago, of Glaxo Wellcome with SmithKline Beecham, creating global behemoth GSK, which demonstrated that “the process was not as easily ‘industrialisable’ as people...
...company SmithKline Beecham....
...Beecham to create GSK....
...A veteran of the pharmaceuticals industry, he experienced a big merger while working for SmithKline Beecham when it combined with Glaxo Wellcome in 2000....
...That was what happened in the last big round of consolidation, around the turn of the millennium, through Glaxo Wellcome’s merger with SmithKline Beecham and Pfizer’s with Warner-Lambert and Wyeth....
...I was an investor in Glaxo Wellcome and SmithKline Beecham through most of the 1990s, before their merger into one entity....
...He notes that Allergan was spun out of SmithKline in 1989 when it merged with Beecham....
...Megamergers such as Pfizer’s $90bn takeover of Warner-Lambert in 1999 and SmithKline’s $72bn merger with Glaxo had struggled to produce growth....
...A Pfizer-AstraZeneca deal would rival the $74bn merger between GlaxoWellcome and SmithKline Beecham in 2000 as the biggest in industry history, and outstrip Pfizer’s own record $68bn acquisition of Wyeth...
...A chartered accountant, he joined SmithKline, a predecessor company of GSK, in 1989....
...Others are following, with Glaxo SmithKline and Merck among the companies testing rival vaccines....
...As Glaxo Wellcome chief, he oversaw its merger with SmithKline Beecham in 2000, and stepped down in 2002 at the age of 60....
...Mr Garnier led SmithKline before its 2001 merger with Glaxo Wellcome....
...He was also finance director at BG Group and chief financial officer at SmithKline Beecham, which merged with Glaxo Wellcome in 2000 to createGlaxoSmithKline....
...Sinclair Beecham, the co-founder of Pret A Manger, the sandwich retail chain, was a fellow speaker....
...GSK, formed by a merger between Glaxo Wellcome and SmithKline Beecham in 2000, knows size alone is no cure-all....
...In 1999, Smithkline Beecham held a 29 per cent stake in the group. Quest’s laboratories provide test for cancers, cardiovascular diseases, thyroid disorders, and infectious diseases....
...unit to co-operate in his research on beta blockers....
...Beecham in 1988....
...The Shanghai Institute of Materia Medica (Simm), founded in the 1930s and reinforced through co-operation with international pharmaceutical companies over the past decade, is one of many organisations that...
...The company has evolved since Mr Garnier sparked a wave of industry consolidation in 2000, when he took SmithKline Beecham into what was then the UK’s largest merger, with Glaxo Wellcome....
...Through his subsequent work for SmithKline, and the influence of his work on Glaxo, Black was the architect of Britain’s broader success in the industry....
International Edition